Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atrial fibrillation (4) 4
care and treatment (3) 3
index medicus (3) 3
patients (3) 3
stroke (3) 3
antagonists (2) 2
anticoagulants (2) 2
arrhythmia (2) 2
atrial fibrillation - drug therapy (2) 2
biology and life sciences (2) 2
cardiac & cardiovascular systems (2) 2
cardiology (2) 2
diagnostic medicine (2) 2
drug therapy (2) 2
female (2) 2
fibrillation (2) 2
health risks (2) 2
heart failure (2) 2
hemorrhage (2) 2
humans (2) 2
male (2) 2
medicine (2) 2
medicine and health sciences (2) 2
middle aged (2) 2
mortality (2) 2
multidisciplinary sciences (2) 2
outcomes (2) 2
pathology and laboratory medicine (2) 2
pharmaceutics (2) 2
prospective studies (2) 2
registries (2) 2
research article (2) 2
risk factors (2) 2
science (2) 2
signs and symptoms (2) 2
stroke - prevention & control (2) 2
therapy (2) 2
treatment outcome (2) 2
usage (2) 2
vascular medicine (2) 2
vitamin k (2) 2
warfarin (2) 2
1506 (1) 1
1st year (1) 1
2016 esc guidelines (1) 1
610 medicine & health (1) 1
abridged index medicus (1) 1
ace inhibitor therapy (1) 1
acute coronary syndromes (1) 1
administration, oral (1) 1
age (1) 1
age factors (1) 1
aged (1) 1
aged, 80 and over (1) 1
alcohol (1) 1
alcoholic beverages (1) 1
aldosterone (1) 1
analysis (1) 1
antagonist oral anticoagulants (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulants - adverse effects (1) 1
anticoagulants - therapeutic use (1) 1
anticoagulation (1) 1
antiplatelet therapy (1) 1
antiplatyhelmintic agents - administration & dosage (1) 1
antiplatyhelmintic agents - adverse effects (1) 1
antiplatyhelmintic agents - therapeutic use (1) 1
antithrombotic therapy (1) 1
antithrombotic treatment patterns (1) 1
arrhythmias and sudden death (1) 1
asia (1) 1
atrial fibrillation - diagnosis (1) 1
atrial fibrillation - epidemiology (1) 1
atrial fibrillation - mortality (1) 1
b vitamins (1) 1
biochemistry (1) 1
bleeding (1) 1
blood pressure (1) 1
cardiac arrhythmia (1) 1
cardiovascular disease (1) 1
cardiovascular therapy (1) 1
cerebrovascular diseases (1) 1
chemical compounds (1) 1
chemistry (1) 1
chronic kidney disease (1) 1
chronic kidney-disease (1) 1
clinic for cardiology (1) 1
clinical-practice (1) 1
comorbidity (1) 1
coronary artery disease (1) 1
coronary vessels (1) 1
dabigatran (1) 1
death rates (1) 1
demography (1) 1
diabetes (1) 1
diabetes mellitus (1) 1
diagnosis (1) 1
disease prevention (1) 1
diuretics (1) 1
drug-use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
by Haas, Sylvia and ten Cate, Hugo and Accetta, Gabriele and Angchaisuksiri, Pantep and Bassand, Jean-Pierre and Camm, A. John and Corbalan, Ramon and Darius, Harald and Fitzmaurice, David A and Goldhaber, Samuel Z and Goto, Shinya and Jacobson, Barry and Kayani, Gloria and Mantovani, Lorenzo G and Misselwitz, Frank and Pieper, Karen and Schellong, Sebastian M and Stepinska, Janina and Turpie, Alexander G. G and van Eickels, Martin and Kakkar, Ajay K and GARFIELD-AF Investigators and for the GARFIELD-AF Investigators
PLoS One, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, p. e0164076
Aims Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of... 
STROKE | MORTALITY | MANAGEMENT | SCORE | MULTIDISCIPLINARY SCIENCES | ANTITHROMBOTIC THERAPY | INTENSITY | RISK | ANTICOAGULATION | Antiplatyhelmintic Agents - administration & dosage | Antiplatyhelmintic Agents - therapeutic use | Stroke - prevention & control | Prospective Studies | Anticoagulants - administration & dosage | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Risk Factors | Anticoagulants - therapeutic use | Male | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Vitamin K - antagonists & inhibitors | Atrial Fibrillation - mortality | Female | Registries | Hemorrhage - chemically induced | Antiplatyhelmintic Agents - adverse effects | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Patient outcomes | Atrial fibrillation | Mortality | Anticoagulants | Stroke | Fibrillation | Health risks | Electrocardiography | Antagonists | Patients | Bleeding | Embolism | Risk factors | Vitamin K
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
by Camm, A John and Accetta, Gabriele and Ambrosio, Giuseppe and Atar, Dan and Bassand, Jean-Pierre and Berge, Eivind and Cools, Frank and Fitzmaurice, David A and Goldhaber, Samuel Z and Goto, Shinya and Haas, Sylvia and Kayani, Gloria and Koretsune, Yukihiro and Mantovani, Lorenzo G and Misselwitz, Frank and Oh, Seil and Turpie, Alexander G G and Verheugt, Freek W A and Kakkar, Ajay K and GARFIELD-AF Investigators
Heart, ISSN 1355-6037, 02/2017, Volume 103, Issue 4, pp. 307 - 314
ObjectiveWe studied evolving antithrombotic therapy patterns in patients with newly diagnosed non-valvular atrial fibrillation (AF) and ≥1 additional stroke... 
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | STROKE PREVENTION | RISK-FACTOR | WARFARIN | TRANSIENT ISCHEMIC ATTACK | GLOBAL ANTICOAGULANT REGISTRY | GUIDELINES | EURO HEART SURVEY | SUBGROUP ANALYSIS | THROMBOEMBOLISM | Prospective Studies | Age Factors | Humans | Middle Aged | Stroke - diagnosis | Male | Fibrinolytic Agents - adverse effects | Time Factors | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Atrial Fibrillation - diagnosis | Stroke - prevention & control | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Treatment Outcome | Practice Patterns, Physicians' - trends | Guideline Adherence | Atrial Fibrillation - epidemiology | Sex Factors | Aged | Fibrinolytic Agents - administration & dosage | Practice Guidelines as Topic | Stroke (Disease) | Care and treatment | Usage | Atrial fibrillation | Diagnosis | Thrombolytic drugs | Patients | Health aspects | Risk factors | Arrhythmias and Sudden Death | 1506 | Stroke
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
by Bassand, Jean-Pierre and Accetta, Gabriele and Al Mahmeed, Wael and Corbalan, Ramon and Eikelboom, John and Fitzmaurice, David A and Fox, Keith A. A and Gao, Haiyan and Goldhaber, Samuel Z and Goto, Shinya and Haas, Sylvia and Kayani, Gloria and Pieper, Karen and Turpie, Alexander G.G and Van Eickels, Martin and Verheugt, Freek W. A and Kakkar, Ajay K and GARFIELD-AF Investigators and for the GARFIELD-AF Investigators
PLoS ONE, ISSN 1932-6203, 01/2018, Volume 13, Issue 1, p. e0191592
Background The factors influencing three major outcomes +/- death, stroke/systemic embolism (SE), and major bleeding +/- have not been investigated in a large... 
MORTALITY | PERSISTENT | GLUCOSE CONTROL | ORAL ANTICOAGULATION | GUIDELINE-RECOMMENDED THERAPIES | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | 2016 ESC GUIDELINES | OUTCOMES | CHRONIC KIDNEY-DISEASE | CLINICAL-PRACTICE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
by Haas, Sylvia and Camm, A John and Bassand, Jean-Pierre and Angchaisuksiri, Pantep and Cools, Frank and Corbalan, Ramon and Gibbs, Harry and Jacobson, Barry and Koretsune, Yukihiro and Mantovani, Lorenzo G and Misselwitz, Frank and Panchenko, Elizaveta and Ragy, Hany Ibrahim and Stepinska, Janina and Turpie, Alexander GG and Sawhney, Jitendra PS and Steffel, Jan and Lim, Toon Wei and Pieper, Karen S and Virdone, Saverio and Verheugt, Freek WA and Kakkar, Ajay K and GARFIELD-AF Investigators
American Heart Journal, ISSN 0002-8703, 07/2019, Volume 213, pp. 35 - 46
A principal aim of the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) was to document changes in treatment practice for patients... 
CARDIAC & CARDIOVASCULAR SYSTEMS | DRUG-USE | DABIGATRAN | WARFARIN | VITAMIN-K ANTAGONISTS | ANTITHROMBOTIC TREATMENT PATTERNS | RENAL-FUNCTION | 1ST YEAR | ANTAGONIST ORAL ANTICOAGULANTS | OUTCOMES | TRENDS | Prevention | Stroke (Disease) | Care and treatment | Usage | Atrial fibrillation | Analysis | Elderly people | Therapy | Cardiac arrhythmia | Physicians | Alcohol | Cardiovascular disease | Antagonists | Family medical history | Heterogeneity | Vascular diseases | Fibrillation | Blood pressure | Heart diseases | Emergency medical services | Age | Vitamin K | Heart failure | Medical personnel | Hypertension | Anticoagulants | Stroke | Kidneys | Risk groups | Diabetes mellitus | Health risks | Shrinkage | Regression analysis | Patients | Coronary artery disease | Studies | Heart rate | Disease prevention | Coronary vessels | Renal failure | Alcoholic beverages | Kidney diseases | Diabetes | Acute coronary syndromes | Elderly | Geriatrics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.